Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.
Status:
COMPLETED
Trial end date:
2024-01-10
Target enrollment:
Participant gender:
Summary
A clinical trial comparing the potential effect of 2 different modalities (Nd-YAG Laser Versus Epidermal growth factor injection) on pain reduction in patients suffering from myogenic tempromandibular disorder.